ATLASense develops REPHAEL, giving clinicians continuous physiological visibility to detect early patient decline and safely expand care from hospital to home.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free